Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Summary

The primary purpose of this Registry is to assess procedural safety and long-term effectiveness of catheter ablations in the treatment of subjects with PAF, PsAF, and VA. The Registry will utilize real world clinical data obtained from the use of commercially available CARTO™ technologies under the authority of a health care practitioner within a legitimate practitioner-subject relationship. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term effectiveness of catheter ablation with novel technologies for arrhythmia patients.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation
• Ventricular Arrhythmia

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

18 years and older

Sex

All

Healthy volunteers

Not accepted

Sponsor

Heart Rhythm Clinical and Research Solutions, LLC

Last updated on ClinicalTrials.gov

September 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites